Oragenics
OGEN
10 hedge funds and large institutions have $16.5M invested in Oragenics in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
11% more funds holding
Funds holding: 9 → 10 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
40% less capital invested
Capital invested by funds: $27.6M → $16.5M (-$11.1M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$18.3K |
| 2 |
MLM
Mount Lucas Management
Newtown,
Pennsylvania
|
+$18.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IA
IFP Advisors
Tampa,
Florida
|
-$53K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$36.6K |
| 3 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$18.3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2K |
OGEN Hedge Fund Activity: Q1 2016 in Review
10 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q1 2016, worth a combined $16.5M — down 40% from $27.6M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new OGEN positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $18.3K. The largest seller was IFP Advisors, exiting entirely with an estimated $53K sold.
- 10 institutional investors held Oragenics (OGEN) as of Q1 2016, up from 9 in Q4 2015.
- Funds reported $16.5M of Oragenics stock for Q1 2016, down 40% quarter-over-quarter.
- 2 funds opened new Oragenics positions in Q1 2016 and 1 closed out, a net change of +1 holder.
- The largest Oragenics buyer in Q1 2016 was Citadel Advisors, an estimated $18.3K added.
- The largest Oragenics seller in Q1 2016 was IFP Advisors, an estimated $53K sold.
Based on aggregated 13F filings for Q1 2016.